Medaysis Co.
Medaysis Co. is a Manufacturer based in United States of America. Main products and services: Primary antibodies, IHC IF and ISH polymer detection kits, mutation detection PCR kits, human tissues.
Company Profile
Located in the San Francisco Bay Area, Medaysis develops and delivers primary antibodies for immunohistochemistry (IHC), non-biotin labelled secondary antibodies for immunofluorescence (IF) and Multiplexing IF, probes for in situ hybridization (ISH), and associated detection reagents for cancer, infectious diseases, neuroscience and other life science research. Medaysis provides a comprehensive portfolio of products including 600 primary antibodies, 70 IF detection kits, a variety of tissue blocks and a broad range of detection reagents and ancillary products.
We are passionate and strive to continuously introduce novel antibodies and new solutions to enable pathologists, histologists and researchers to design experiments, improve test accuracy and achieve reliable results. We recently introduced ultra-sensitive and specific PCR-based mutation detection systems designed with novel and proprietary primers that are able to detect 1% or less common somatic mutations in the genes.
Our mission is to provide advanced technologies and quality solutions that will empower the innovation and improve the practice of anatomic and molecular pathology professionals, ultimately to develop accurate diagnostic assays and personalized healthcare to benefit the patients and well-being of individuals around the world.